These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11284414)

  • 1. [Prevention of instant restenosis after coronary angioplasty by implantation of rapamycin-coated stents].
    Hansen PR; Abildgaard U; Galløe AM; Kassis E
    Ugeskr Laeger; 2001 Mar; 163(12):1714. PubMed ID: 11284414
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous coronary intervention and drug-eluting stents.
    Yang YM; Moussa I
    CMAJ; 2005 Feb; 172(3):323-5. PubMed ID: 15684110
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 4. The "0%" restenosis study.
    Colombo A
    Ital Heart J; 2002 Oct; 3(10):559-6. PubMed ID: 12478812
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus-eluting stents: the novel application of basic science to coronary artery disease.
    Foley DP
    Ir Med J; 2002 Oct; 95(9):283. PubMed ID: 12470008
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral rapamycin in the treatment of diffuse proliferative in-stent restenosis in a patient with small reference vessel.
    Rodriguez AE; Fernández Pereira C; Rodríguez Alemparte M
    J Invasive Cardiol; 2003 Sep; 15(9):515-8. PubMed ID: 12947212
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dollars and sense of drug-eluting stents.
    Brophy JM
    CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry.
    Liu HB; Xu B; Gao RL; Yang YJ; Yao M; Qin XW; Wu YJ; Yuan JQ; Ma WH; Qiao SB; Chen JL
    Chin Med J (Engl); 2006 Apr; 119(7):609-11. PubMed ID: 16620705
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary-artery stents.
    Serruys PW; Kutryk MJ; Ong AT
    N Engl J Med; 2006 Feb; 354(5):483-95. PubMed ID: 16452560
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.
    Pan M; de Lezo JS; Medina A; Romero M; Segura J; Pavlovic D; Delgado A; Ojeda S; Melián F; Herrador J; Ureña I; Burgos L
    Am Heart J; 2004 Nov; 148(5):857-64. PubMed ID: 15523318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial).
    Rodriguez AE; Alemparte MR; Vigo CF; Pereira CF; Llaurado C; Russo M; Virmani R; Ambrose JA
    J Invasive Cardiol; 2003 Oct; 15(10):581-4. PubMed ID: 14519892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang.
    Kunadian B; Vijayalakshmi K; de Belder MA
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 17. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H; Pedersen SS; Serruys PW; Erdman RA; van Domburg RT
    J Affect Disord; 2007 Apr; 99(1-3):173-9. PubMed ID: 17049996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents.
    Kim SH; Kim EJ; Suh SY; Choi CU; Kim JW; Rha SW; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2007 Sep; 120(3):423-5. PubMed ID: 17097164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-eluting stents: does a great stent still need a good interventionalist?
    Carrozza JP
    J Am Coll Cardiol; 2004 Mar; 43(6):1116-7. PubMed ID: 15028376
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.